CD274 and cancer: The combination of immunotherapy with chemotherapy can augment the formation of new antigenic complexes, promote the immunogenicity of cancer cells, induce immune cell death, modify the cytokine environment within the TME, and result in the redistribution and increased expression of PD-L1 on tumor cells[138].